Top Wall Street Stories: BancFirst Corporation (NASDAQ:BANF), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Celgene Corporation (NASDAQ:CELG), Gladstone Investment (NASDAQ:GAIN), Genesee & Wyoming (NYSE:GWR)

BancFirst Corporation (NASDAQ:BANF) belongs to Financial sector. Its net profit margin is 33.20% and weekly performance is 2.82%. On last trading day company shares ended up $66.44. BancFirst Corporation (NASDAQ:BANF) distance from 50-day simple moving average (SMA50) is 8.42%. BancFirst Corp (NASDAQ:BANF) on Tuesday said it has agreed to acquire CSB Bancshares Inc and its subsidiary bank, Bank of Commerce, with locations in Yukon, Mustang, and El Reno, Oklahoma. The deal is to be completed during October 2015. Bank of Commerce has about $202 million in total assets, $139 million in loans, $180 million in deposits, and $21 million in equity capital. The bank will operate under its present name until it is merged into BancFirst, which is expected to be during the fourth quarter of 2015.

Applied Genetic Technologies Corporation (NASDAQ:AGTC) shares moved down -3.08% in last trading session and ended the day at $18.90. AGTC return on assets is -22.00%. Applied Genetic Technologies Corporation (NASDAQ:AGTC) quarterly performance is -16.81%. On July 6, Applied Genetic Technologies Corporation (NASDAQ:AGTC) announced that Sue Washer, President and CEO will present at the Cantor Fitzgerald Healthcare Conference on July 8, 2015 at 10:15am in New York. Ms. Washer will provide a corporate overview and will discuss key corporate milestones related to AGTC’s lead development programs, including X-linked retinoschisis (XLRS), achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP).

On 14 July, Celgene Corporation (NASDAQ:CELG) shares moved up 1.62% and was closed at $122.85. CELG EPS growth in last 5 year was 23.60%. Celgene Corporation (NASDAQ:CELG) year to date (YTD) performance is 9.82%. Cancer drug maker Celgene Corporation (NASDAQ:CELG) said it will buy Receptos for $7.32 billion in cash, gaining a drug Receptos is studying as a treatment for multiple sclerosis and ulcerative colitis. Celgene (CELG) agreed to pay $232 per share for Receptos, and the companies valued the deal at $7.2 billion excluding Receptos’ cash on hand. That’s a 12 percent premium from the Tuesday closing price of Receptos shares.

Gladstone Investment Corporation (NASDAQ:GAIN) ended the last trading day at $8.16. Company weekly volatility is calculated as 1.07% and price to cash ratio as 50.41. Gladstone Investment Corporation (NASDAQ:GAIN) showed a weekly performance of 0.74%. Gladstone Investment Corporation (NASDAQ:GAIN)., named Julia Ryan finance chief and treasurer. Ms. Ryan, who is currently the chief accounting officer of the company, succeeds Melissa Morrison, who will serve as finance chief and treasurer of Gladstone Capital Corp., an affiliate of Gladstone Investment. The transition started in April 2015, when the company appointed Ms. Ryan as chief accounting officer, according to a press release.

Genesee & Wyoming Inc. (NYSE:GWR) shares moved down -1.12% in last trading session and ended the day at $71.69. GWR Gross Margin is 75.60% and its return on assets is 4.20%. Genesee & Wyoming Inc. (NYSE:GWR) quarterly performance is -24.43%. Genesee & Wyoming Inc. (G&W) (NYSE:GWR) reported traffic volumes for June 2015 and the second quarter of 2015. G&W’s traffic in June 2015 was 153,996 carloads, a decrease of 13,731 carloads, or 8.2%, compared with June 2014. G&W’s same-railroad traffic in June 2015 was 150,626 carloads, a decrease of 17,101 carloads, or 10.2%, compared with June 2014. Traffic from G&W’s Freightliner acquisition, which was completed on March 25, 2015, is not included in this press release.

Leave a Reply

Your email address will not be published. Required fields are marked *